Sign in
8-K

Current Report

Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-070987

Agreement ended · Exit or restructuring costs

  • Item 1.02 Termination of a material definitive agreement
  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading abos-20261101.htm…